The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients
Table 1
Rheumatologic diagnoses and demographic characteristics of 319 patients receiving medical cannabis different rheumatology outpatient clinics in North of Israel.
Type of disease
Number (%)
Age
Gender F:M
Duration of MC use (years)
Duration of disease (years)
Fibromyalgia
260 (81.5)
45 ± 11.8
217:43
2.89 ± 2.1
5.6 ± 3.9
Mechanical back pain
14 (4.4)
59 ± 10.3
6:8
1.9 ± 1.4
10.5 ± 5.4
Physical injury
8 (2.5)
36.6 ± 12.3
2:6
3.2 ± 2.3
7.1 ± 5.2
Rheumatoid arthritis
7 2.2)
41.6 ± 6.5
5:2
1.5 ± 0.85
7.37 ± 4.24
Diabetic neuropathy
7 (2.2)
52.6 ± 10.5
2:5
2.87 ± 1.9
11.86 ± 7.36
Psoriatic arthritis
3 (0.9)
46.3 ± 8.7
1:2
3 ± 1
8.3 ± 2.1
Sacroiliitis
3 (0.9)
35.7 ± 7.5
2:1
2.33 ± 0.58
9.2 ± 3.6
CRPS
3 (0.9)
32.3 ± 5.5
0:3
4.33 ± 1.76
7.2 ± 3.4
Knee osteoarthritis
2 (0.6)
69 ± 4.2
2:0
2.25 ± 1.1
16.2 ± 8.5
FMF
2 (0.6)
31 ± 2.8
0:2
3.25 ± 1.34
19 ± 4.24
Tremor
2 (0.6)
58 ± 19.8
2:0
3.75 ± 3.18
8.28
Osteoporotic fractures
2 (0.6)
69 ± 4.2
2:0
3.25 ± 1.1
11.5 ± 5.6
Spinal stenosis
2 (0.6
59 ± 4.3
1:1
3.5 ± 1.4
8 ± 2.83
Parkinson
2 (0.6)
53 ± 6.4
1:1
2.4 ± 2.26
16.5 ± 7.8
Osteochondroma
1 (0.3)
25
0:1
3.5
12
PVD
1 (0.3)
65
0:1
2.75
18
Mean ± standard deviation. CRPS = complex regional pain syndrome, FMF = familial Mediterranean fever, PVD = peripheral vascular disease, MC = medical cannabis, and F:M = female:male.
